1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Saumoy M, Llibre JM, Terrón A, Knobel H, Arribas J, Domingo P, Arroyo-Manzano D, Rivero A, Moreno S, Podzamczer D.

    Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice.

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 33(1): 29-32. Nº de citas: 4

    [doi:10.1089/AID.2015.0386]

  • Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho EM, Ephros M, Jeronimo S, Magill A.

    Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

    CLINICAL INFECTIOUS DISEASES . 63(12): 202-264. Nº de citas: 140

    [doi:10.1093/cid/ciw670]

  • García-Fernández S, Morosini MI, Cobo M, Foruny JR, López-Sanromán A, Cobo J, Romero J, Cantón R, Del Campo R.

    Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain.

    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE . 86(4): 470-471. Nº de citas: 19

    [doi:10.1016/j.diagmicrobio.2016.09.004]

  • Vallejo A, Monge-Maillo B, Gutiérrez C, Norman FF, López-Vélez R, Pérez-Molina JA.

    Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.

    ACTA TROPICA . 164: 117-124. Nº de citas: 21

    [doi:10.1016/j.actatropica.2016.09.010]

  • Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA, Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Netwo.

    Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY . 45(6): 2038-2049. Nº de citas: 25

    [doi:10.1093/ije/dyv295]

  • .

    Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies

    CLINICAL INFECTIOUS DISEASES . 63(10): 1373-1379. Nº de citas: 19

    [doi:10.1093/cid/ciw562]

  • Norman FF, Chamorro S, Vázquez A, Sánchez-Seco MP, Pérez-Molina JA, Monge-Maillo B, Vivancos MJ, Rodríguez-Dominguez M, Galán JC, de Ory F, López-Vélez R.

    Sequential Chikungunya and Zika Virus Infections in a Traveler from Honduras.

    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE . 95(5): 1166-1168. Nº de citas: 15

    [doi:10.4269/ajtmh.16-0426]

  • López-Medrano F, Fernández-Ruiz M, Silva JT, Carver PL, van Delden C, Merino E, Pérez-Saez MJ, Montero M, Coussement J, de Abreu Mazzolin M, Cervera C, Santos L, Sabé N, Scemla A, Cordero E, Cruzado-Vega L, Martín-Moreno PL, Len Ó, Rudas E, Ponce de León A, Arriola M, Lauzurica R, David M, González-Rico C, Henríquez-Palop F, Fortún J, Nucci M, Manuel O, Paño-Pardo JR, Montejo M, Muñoz P, Sánchez-Sobrino B, Mazuecos A, Pascual J, Horcajada JP, Lecompte T, Moreno A, Carratalà J, Blanes M, Hernández D, Del Fariñas MC, Andrés A, Aguado JM.

    Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.

    AMERICAN JOURNAL OF TRANSPLANTATION . 16(11): 3220-3234. Nº de citas: 40

    [doi:10.1111/ajt.13837]

  • Zaragoza R, Aguado JM, Ferrer R, Rodríguez AH, Maseda E, Llinares P, Grau S, Muñoz P, Fortún J, Bouzada M, Pozo JC, León R, EPICO Project Group.

    EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipients.

    REVISTA IBEROAMERICANA DE MICOLOGIA . 33(4): 187-195. Nº de citas: 8

    [doi:10.1016/j.riam.2016.02.001]

  • Troya J, Ryan P, Ribera E, Podzamczer D, Hontañón V, Terrón JA, Boix V, Moreno S, Barrufet P, Castaño M, Carrero A, Galindo MJ, Suárez-Lozano I, Knobel H, Raffo M, Solís J, Yllescas M, Esteban H, González-García J, Berenguer J, Imaz A.

    Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

    Plos One . 11(10): . Nº de citas: 7

    [doi:10.1371/journal.pone.0164455]

  • Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Pintado V, Doi Y, Tuon FF, Karaiskos I, Machuca I, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J, Investigators from the REIPI/ESGBIS/INCREMENT Group.

    A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

    MAYO CLINIC PROCEEDINGS . 91(10): 1362-1371. Nº de citas: 69

    [doi:10.1016/j.mayocp.2016.06.024]

  • Estrada V, Monge S, Gómez-Garre MD, Sobrino P, Masiá M, Berenguer J, Portilla J, Viladés C, Martínez E, Blanco JR.

    Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy

    HIV MEDICINE . 17(9): 653-661. Nº de citas: 16

    [doi:10.1111/hiv.12368]

  • Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee.

    Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 34(8): .

    [doi:10.1016/j.eimc.2016.02.004]

  • Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee.

    Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 34(8): 517-523. Nº de citas: 3

    [doi:10.1016/j.eimc.2016.02.025]

  • Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JS, Lane HC, Larder BA, RDI Data and Study Group.

    An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 71(10): 2928-2937. Nº de citas: 7

    [doi:10.1093/jac/dkw217]

  • Ramos A, Romero Y, Sánchez-Romero I, Fortún J, Paño JR, Pemán J, Gurguí M, Rodríguez-Baño J, Padilla B.

    Risk factors, clinical presentation and prognosis of mixed candidaemia: a population-based surveillance in Spain.

    Mycoses . 59(10): 636-643. Nº de citas: 5

    [doi:10.1111/myc.12516]

  • Fernandez-Garcia MD, Bangert M, de Ory F, Potente A, Hernandez L, Lasala F, Herrero L, Molero F, Negredo A, Vázquez A, Minguito T, Balfagón P, de la Fuente J, Puente S, Ramírez de Arellano E, Lago M, Martinez M, Gascón J, Norman F, Lopez-Velez R, Sulleiro E, Pou D, Serre N, Roblas RF, Tenorio A, Franco L, Sanchez-Seco MP.

    Chikungunya virus infections among travellers returning to Spain, 2008 to 2014

    Eurosurveillance . 21(36): 2-10. Nº de citas: 3

    [doi:10.2807/1560-7917.ES.2016.21.36.30336]

  • Ta-Tang TH, Luz SL, Merino FJ, de Fuentes I, López-Vélez R, Almeida TA, Lanza M, Abrahim CM, Rubio JM.

    Atypical Mansonella ozzardi Microfilariae from an Endemic Area of Brazilian Amazonia.

    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE . 95(3): 629-632. Nº de citas: 8

    [doi:10.4269/ajtmh.15-0654]